These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23800583)

  • 1. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Crowley K; Goto S; Ohman EM; Bakris GL; Perlstein TS; Kinlay S; Bhatt DL;
    Eur Heart J; 2013 Apr; 34(16):1204-14. PubMed ID: 23144048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment is associated with medication nonadherence in asymptomatic carotid stenosis.
    Kirkpatrick AC; Vincent AS; Guthery L; Prodan CI
    Am J Med; 2014 Dec; 127(12):1243-6. PubMed ID: 25168078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular morbidity associated with nonadherence to statin therapy.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW
    Pharmacotherapy; 2005 Aug; 25(8):1035-43. PubMed ID: 16207093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
    Rodriguez F; Cannon CP; Steg PG; Kumbhani DJ; Goto S; Smith SC; Eagle KA; Ohman EM; Umez-Eronini AA; Hoffman E; Bhatt DL;
    Clin Cardiol; 2013 Dec; 36(12):721-7. PubMed ID: 24166484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.
    McAlister FA; Majumdar SR; Lin M; Bakal J; Fradette M; Anderson T
    Can J Cardiol; 2014 Dec; 30(12):1627-32. PubMed ID: 25307535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
    Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
    Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.
    Sjölander M; Eriksson M; Glader EL
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):911-9. PubMed ID: 22069216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice.
    Heeley E; Anderson C; Patel A; Cass A; Peiris D; Weekes A; Chalmers J
    Int J Stroke; 2012 Dec; 7(8):649-54. PubMed ID: 21978147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy.
    Rublee DA; Chen SY; Mardekian J; Wu N; Rao P; Boulanger L
    Am J Ther; 2012 Jan; 19(1):24-32. PubMed ID: 20838204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ
    Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
    Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
    JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.
    Lindhardsen J; Ahlehoff O; Gislason GH; Madsen OR; Olesen JB; Torp-Pedersen C; Hansen PR
    Ann Rheum Dis; 2012 Sep; 71(9):1496-501. PubMed ID: 22402144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.